Using Virtual Reality and Sensor Technology to Enhance Outcomes From Treatment for Binge Eating

September 8, 2021 updated by: Drexel University
This study evaluates whether virtual-reality-based inhibitory control trainings are more effective than computerized trainings in reducing binge eating symptomatology. These trainings are used to improve people's ability to resist their impulses towards highly palatable foods (such as chips or cookies). These trainings also offer promise as a companion to Cognitive Behavioral Therapy, an often used and relatively effective therapeutic methodology.

Study Overview

Detailed Description

Low levels of inhibitory control (i.e., the ability to withhold a quick, automatic response) is strongly linked with binge eating pathology. One of the most widely used and effective treatments for binge eating leaves 40-60% of patients partially or fully symptomatic at post-treatment. Researchers have begun to investigate the efficacy of computerized inhibitory control trainings (ICTs), which are tasks in which participants are asked repeatedly withhold a keypress responses to food stimuli. The intention of these trainings is to improve inhibitory control and to, in turn, reduce dysregulated eating behavior.

Results for the efficacy of ICTs are promising, yet mixed. ICTs that are gamified (i.e., turned into a video game) using virtual reality technology have high potential to address the barriers which may be limiting the efficacy of previous ICTs. The current study aims to finalize development and test the feasibility, acceptability and preliminary efficacy of the first-ever virtual reality ICT (VR-ICT) for individuals with binge eating pathology.

Thus, the study's aims are as follows:

Primary aim 1: Enhance features of a previously developed, VR-based ICT for binge eating.

Primary aim 2: Examine the feasibility and acceptability of the VR ICT training program.

Primary aim 3: Examine the efficacy of VR-ICT versus a non-VR ICT and ICT vs. sham training, for reductions in binge eating from pre to post-treatment and at follow-up.

Based on previous research and data from a pilot study, the investigators hypothesize a) that the VR ICT training program will be feasible and acceptable and b) that the VR-ICT and ICT will produce superior reductions in binge eating from pre- to post-treatment and at follow-up, as compared, respectively, with the non-VR ICT and the sham ICT.

Study Type

Interventional

Enrollment (Actual)

41

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • Drexel Universitty

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Speak, write, and understand English
  • Age 18-65 years
  • Experience objectively or subjectively large binge eating episodes once per week or more for the past three months

    • Objectively large binge episodes are defined by the Eating Disorder Examination (EDE; a measure employed in this study) as consisting of at least two full meals of two courses at each (i.e., four courses total) or of at least three main courses
    • Participants, also as per the EDE, must also experience a loss of control over their eating for the given episode to qualify as an objective binge
    • Subjective binges are those which do not meet the food quantity criteria but during which participants experience a loss of control and feel they have eaten too much
  • If applicable, have stable psychiatric medication for the past three months.

Exclusion Criteria:

  • Acute suicide risk
  • Are planning on receiving psychological treatment for binge eating during the course of their participation in the study
  • Are planning to participate in a structured weight loss treatment program (e.g., WeightWatchers, behavioral weight loss treatment) during the course of their participation in the study
  • Are currently receiving weight loss treatment
  • Have a BMI below 17.5
  • Co-morbid clinically significant psychological disorder that would require attention beyond the study treatment (i.e., bipolar I disorder, substance dependence, and/or psychotic conditions)
  • Diagnosis of intellectual disability or autism spectrum disorder
  • History of neurological condition or traumatic brain injury
  • Current pregnancy or intention to become pregnant during the course of their participation
  • History of bariatric surgery
  • Are currently using a stimulant medication (e.g., Ritalin, Adderall)
  • No internet connection at home

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: FACTORIAL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: VR ICT
Virtual-reality-based inhibitory control training done daily at home for 6 weeks.
Uses virtual reality for the inhibitory control training, rather than a relatively simplistic computerized training.
Other Names:
  • VR
Uses an active inhibitory control training which includes a "stop" signal.
Other Names:
  • ICT
SHAM_COMPARATOR: VR Sham ICT
Virtual-reality-based sham inhibitory control training (i.e., one that does not include a "stop" signal and that thus does not truly train inhibitory control) done daily at home for 6 weeks.
Uses virtual reality for the inhibitory control training, rather than a relatively simplistic computerized training.
Other Names:
  • VR
Uses an inhibitory control training which does not include a "stop" signal.
ACTIVE_COMPARATOR: Non-VR ICT
Computerized inhibitory control training done daily at home for 6 weeks.
Uses an active inhibitory control training which includes a "stop" signal.
Other Names:
  • ICT
Uses a relatively simplistic computerized training.
SHAM_COMPARATOR: Non-VR Sham ICT
Computerized sham inhibitory control training (i.e., one that does not include a "stop" signal and that thus does not truly train inhibitory control) done daily at home for 6 weeks.
Uses an inhibitory control training which does not include a "stop" signal.
Uses a relatively simplistic computerized training.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Protocol recruitment
Time Frame: The investigators will assess adherence at follow-up assessments (18 weeks after baseline assessment)
This outcome will be assessed according to whether the investigators can recruit at least 40 participants. This forms the first half of the assessment of the protocol's feasibility.
The investigators will assess adherence at follow-up assessments (18 weeks after baseline assessment)
Protocol retention
Time Frame: The investigators will assess adherence at follow-up assessments (18 weeks after baseline assessment)
This outcome will be assessed according to whether > 75% of participants completed all assessments. This forms the second half of the assessment of the protocol's feasibility.
The investigators will assess adherence at follow-up assessments (18 weeks after baseline assessment)
Protocol adherence
Time Frame: The investigators will assess adherence at follow-up assessments (18 weeks after baseline assessment).
This outcome will be assessed according to whether participants completed ≥ 75% of all daily training sessions. This forms the first half of the assessment of the protocol's acceptability.
The investigators will assess adherence at follow-up assessments (18 weeks after baseline assessment).
Protocol satisfaction
Time Frame: The investigators will assess satisfaction at follow-up assessments (18 weeks after baseline assessment).
This outcome will be assessed according to whether the average participant rating is >= 4 on all questions on the Technology Reactions and Acceptance and Technology Expectancy Questionnaires. This forms the second half of the assessment of the protocol's acceptability.
The investigators will assess satisfaction at follow-up assessments (18 weeks after baseline assessment).
Impact of VR + ICT vs. VR + Sham on binge eating frequency
Time Frame: The investigators will assess efficacy at post-treatment (6 weeks after baseline) and at follow-up (18 weeks after baseline).
This outcome will be assessed according to whether participation in the VR + ICT condition produces a larger change in binge eating episodes than does participation in the VR + Sham condition, as measured using the binge module of the Eating Disorder Examination version 17.
The investigators will assess efficacy at post-treatment (6 weeks after baseline) and at follow-up (18 weeks after baseline).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 14, 2019

Primary Completion (ACTUAL)

August 5, 2020

Study Completion (ACTUAL)

August 5, 2020

Study Registration Dates

First Submitted

October 22, 2019

First Submitted That Met QC Criteria

September 8, 2021

First Posted (ACTUAL)

September 13, 2021

Study Record Updates

Last Update Posted (ACTUAL)

September 13, 2021

Last Update Submitted That Met QC Criteria

September 8, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Binge Eating

Clinical Trials on Virtual-reality-based training

3
Subscribe